The Contraceptive Implant: An Updated Review of the Evidence

Abstract
The etonogestrel implant is a form of highly effective and long-acting reversible contraception, available in the U.S. as Nexplanon® (Merck and Co, Inc., Kenilworth, NJ, U.S.). It is placed under the skin of the upper arm by health care providers and is approved for use up to 3 years. It is more effective than any other method, including the intrauterine devices (IUDs) and permanent sterilization methods. It has few contraindications, and has high rates of satisfaction and continuation. While irregular bleeding is the most common side effect and reason for discontinuation of the method, most women experience reduced bleeding overall, and it can be used to improve dysmenorrhea, menorrhagia, and endometriosis. Complications related to use, insertion, and removal are rare. While the implant has many advantages, it is important for providers of family planning to use a patient-centered approach to counseling about all contraceptives, including highly effective reversible methods, and to support women’s reproductive autonomy.

Source: Current Obstetrics and Gynecology Reports - January 28, 2015 Category: OBGYN Source Type: research